Announcement on Branch Obtaining Drug Registration Certificate
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Announcement on Branch Obtaining Drug Registration Certificate
Filed with SSE ·
6ix hasn’t read this filing yet.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited on 6ix
Earlier from Tianjin Pharmaceutical Da Ren Tang
- Announcement on Convening the Q3 2025 Performance Briefing
- Notice on Convening the 2nd Extraordinary General Meeting in 2025
- Announcement on Attending 2025 Semi-Annual Report Performance Briefing and Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction
- Announcement on Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2024 and "Corporate Value and Return Enhancement" Action Plan 2025
- Announcement on Purchasing Liability Insurance for Directors, Supervisors and Senior Management Members
Later from Tianjin Pharmaceutical Da Ren Tang
- Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2025
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on Appointment of Senior Management Member
- Announcement on Implementation of Quarterly Dividend Distribution for 2025
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
Follow Tianjin Pharmaceutical Da Ren Tang into a list and get an email when it puts out news.
Follow Tianjin Pharmaceutical Da Ren Tang